This review critically evaluates biosensor-based approaches for identifying objective biosensor-based markers of tinnitus, emphasising multimodal integration and clinical translation.
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — biosensor-based tinnitus biomarkers remain at the research stage and are not yet validated for clinical use.
An objective biomarker for tinnitus would transform diagnosis, patient stratification, and treatment monitoring across audiology and neuroscience.
- 01Reviews biosensor approaches for detecting objective, measurable signs of tinnitus.
- 02Covers multimodal biomarker candidates (physiological, neurological, biochemical).
- 03Published in Hearing Research, a leading peer-reviewed audiology journal.
- 04Highlights the current gap between subjective tinnitus assessment and objective measurement.
- 05Findings are exploratory; no single validated biomarker is established.
Biosensor-based multimodal biomarkers can potentially provide objective markers of tinnitus.
studypartially supported- PMID
- 43050753
- DOI
- 10.1016/j.heares.2026.109847.
- Journal
- Hearing Research
- Publication type
- review
- Evidence level
- 1a
- Population
- Literature-based; no primary human or animal subjects
- Intervention
- Biosensor-based multimodal biomarker approaches for tinnitus detection
Primary outcomes
Identification and evaluation of objective biosensor-based biomarkers for tinnitus